1. Introduction
===============

Recently, an increasing number of patients with critical limb ischemia (CLI) have been undergoing medical care at clinical practice sites. Improving the outcome of treatment for these patients is an important and urgent issue. Since 2013, the Japanese Society for Vascular Surgery (JSVS) initiated a nationwide CLI registration and tracking database project to obtain CLI epidemiological data that can be shared among medical staff. The background of CLI limbs, contents of treatment, early outcome, and long-term outcome until five years after surgery, including non-surgical limbs, are registered in this database. The database was named JAPAN Critical Limb Ischemia Database (JCLIMB) and established on the National Clinical Database (NCD). The JCLIMB project's primary objective is to clarify the current status of CLI treatment performed by vascular surgeons in Japan and inform physicians at practice sites, thus improving the quality of medical care. The initial registration data and their tracking data one month after registration in 2013-2016, have already been published.^[@R1]--[@R8])^ In this paper, for the purpose of clarifying the picture of clinical practice of CLI in Japan, we have compiled these data over the past four years. In addition, a part of data is represented by means of graphs to enhance convenience for readers. Graphs were made using overall data.

2. JCLIMB
=========

Registration details, including the definition of CLI, have already been described in the 2013 annual report. CLI to be registered was defined according to TASC II^[@R9])^: chronic ischemic rest pain, ulcers, or gangrene attributable to objectively-proven arterial occlusive disease. CLI diagnosis should be confirmed by ankle pressure (AP) below 50 mmHg or toe pressure (TP) below 30 mmHg in limbs with rest pain, and done by AP below 70 mmHg or TP below 50 mmHg in limbs with ulcer or gangrene.

The same limb can be registered in JCLIMB only once within a five-year tracking period. When the registered limb is treated at different times or different institutions, such data should be added only to the tracking items of each limb in JCLIMB, avoiding registration overlap. However, details of the procedure are registered each time in NCD apart from the registration in JCLIMB. On the other hand, the patient with bilateral CLI can be registered twice for each limb. Based on NCD regulations, fixing JCLIMB data is done as follows:

1.  Initial registration data: Early April in the following year,

2.  Tracking data early after treatment (one month)/six months after treatment: End of December in the following year

3.  Tracking data one year after treatment: End of December after two years

4.  Tracking data two years after treatment: End of December after three years

5.  Tracking data three years after treatment: End of December after four years

6.  Tracking data four years after treatment: End of December after five years

7.  Tracking data five years after treatment: End of December after six years

As a general rule, the timing of tracking data registration is accepted within a ±2-month range until 12 months after treatment, and within a ±3-month range thereafter. Although the day for tracking data fixing is specified, it is made flexible because, in some limbs, follow-up data might be revealed later.

It is very difficult to require facilities participating in NCD to register CLI data since a great number of registration items in JCLIMB would put too much burden on them. Thus, facilities wishing to participate were recruited. Facilities which registered CLI limbs in each year were listed in the appendix in each annual report.

The audit of data registered in JCLIMB and the audit of data regarding vascular surgery registered in NCD was started in 2018. Committee members visit the selected institutes to collate the registered data to the data of clinical chart.

Since JCLIMB is positioned as a registry study on NCD, patient consent to participate in the study, and the ethical review of the study at the time of participation in NCD were adopted.

3. Comments on the Aggregated Data in 2013--2016
================================================

This paper shows the aggregated date which have already been reported in annual reports from 2013 to 2016. The date fixing the data was described in each annual report. For 4 years, 4,784 limbs, those of 3,361 males (70%) and 1,423 females (30%), were registered. All data and extracted data on arteriosclerosis obliterans (ASO) were collected according to the registered items. Since ASO accounted for 98% of all limbs, the overall and ASO data showed similar tendencies. In the comments, ASO data were presented in parentheses. In addition, because the Society for Vascular Surgery (SVS)'s WIfI classification was reported in 2014,^[@R10])^ JCLIMB made several changes and additions to the registered items and the aggregated data on WIfI classification were compiled from the data of 2015 and 2016 annual reports. The site of wound (either gangrene or ulcer) was registered in the item of "Sites of ulcer/gangrene" until 2014, while the ulcer and gangrene have been registered separately since 2015. Accordingly, the numerical values in "Main sites of ulcer/gangrene to be treated" in 2015 and 2016 were used for the 4-years' aggregated data of "Sites of ulcer/gangrene." For the aggregated data of "Vein usage and vein quality," the data in 2015 and 2016 were used. The total figure was not always consistent, mostly due to missing values. The comments to these problems were different depending on each annual report, which should be referred.

(1) Pretreatment patients' background
-------------------------------------

Pretreatment patients' background is shown in [**Tables 1-1**](#table1-1){ref-type="table"} to [](#table1-2){ref-type="table"}[](#table1-3){ref-type="table"}[](#table1-4){ref-type="table"}[](#table1-5){ref-type="table"}[**1-6**](#table1-6){ref-type="table"}. Good blood pressure control was defined as below 140/90 mmHg, without diabetes and renal failure, or below 130/80 mmHg with these diseases. Diabetes control was considered good when hemoglobin A1c was below 7.0% (national glycohemoglobin standardization program value). Dyslipidemia control was considered good when low-density lipoprotein was below 100 and 80 mg/dL in the absence and presence of other arteriosclerotic diseases, respectively. The presence of heart failure was judged clinically. The patient was regarded as having heart failure based on a past history of admission due to heart failure, clinical symptoms of heart failure, a diagnosis of heart failure was confirmed by echocardiography, or reduced cardiac function on echocardiography even with no clinical heart failure symptoms. Renal dysfunction was graded following the new chronic kidney disease severity classification of the "Clinical Practice Guidebook for Diagnosis and Treatment of Chronic Kidney Disease 2012"^[@R11])^: Renal dysfunction was absent when the estimated glomerular filtration rate (eGFR) (mL/min/1.73 m^2^) was 60 or higher, and graded as G3a, G3b, G4, and G5 when eGFR was 45--59, 30--44, 15--29, and below 15, respectively. eGFR below 15 in hemodialysis patients was graded as G5D.

###### Table 1 Patients' background Table 1-1 Patients' background 1

  a\. Total                                                                                                                                                                      
  -------------- -------- ------- ------------ -------------- --------------------- ------- ------------- ---- ---- ---- ------------- ------------- ------------- ------------- -------------
  Rutherford 4   1,079    742     337          549            530                   21.08   1,054         6    2    7    73.4 (9.7)    51.0 (21.6)   57.0 (17.0)   55.1 (8.1)    
  Rutherford 5   2,982    2,098   884          1,513          1,469                 21.05   2,907         28   36   11   73.3 (10.1)   52.4 (16.0)   68.3 (11.9)   75.2 (9.4)    
  Rutherford 6   723      521     202          350            373                   21.14   712           3    5    3    71.0 (10.4)   54.3 (4.5)    70.8 (4.9)    60.0 (6.2)    
  Total          4,784    3,361   1,423        2,412          2,372                 21.08   4,683         37   43   21   73.0 (10.1)   52.4 (16.1)   68.1 (11.6)   66.3 (12.7)   72.7 (10.3)
  b\. ASO                                                                                                                                                                        
                 n        Sex     Laterality   BMI (Median)   Age at registration                                                                                                
  Male           Female   Right   Left         Mean (±SD)                                                                                                                        
  Rutherford 4   1,064    732     332          541            523                   21.08   73.4 (9.7)                                                                           
  Rutherford 5   2,907    2,056   851          1,478          1,429                 21.08   73.3 (10.1)                                                                          
  Rutherford 6   712      514     198          346            366                   21.17   71.0 (10.4)                                                                          
  Total          4,683    3,302   1,381        2,365          2,318                 21.09   73.0 (10.1)                                                                          

Vasculitis: Takayasu's arteritis, collagen disease, Behcet disease, FMD etc., excluding TAO Others: others (including debranch bypasses for TEVAR or EVAR) ASO: arteriosclerosis obliterans, TAO: thromboangiitis obliterans, FMD: fibromuscular dysplasia, BMI: body mass index, TEVAR: thoracic endovascular aortic/aneurysm repair, EVAR: endovascular aortic/aneurysm repair

###### Table 1-2 Patients' background 2

  a\. Total                                                                                                                                                     
  -------------- ------------ ------------------ -------------- ----------------- --------- ------- ------- ------- ----- ------- ------- ----- ------- ------- -----
  Rutherford 4   522          450                107            88                306       163     274     698     107   656     342     81    423     433     223
  Rutherford 5   950          1,590              442            271               928       833     705     1,921   356   1,833   984     165   1,228   1,289   465
  Rutherford 6   172          399                152            84                202       265     221     415     87    448     229     46    295     325     103
  Total          1,644        2,439              701            443               1,436     1,261   1,200   3,034   550   2,937   1,555   292   1,946   2,047   791
  b\. ASO                                                                                                                                                       
                 Diabetes     Diabetes therapy   Hypertension   Dyslipidemia      Smoking                                                                       
  (−)            (+)          Diet therapy       Medication     Insulin therapy   (−)       (+)     (−)     (+)     (−)   (+)                                   
  Management     Management   Management         Ex-smoker      Current smoker                                                                                  
  Good           Poor         Good               Poor           Good              Poor                                                                          
  Rutherford 4   511          446                107            87                305       161     264     693     107   645     338     81    420     426     218
  Rutherford 5   884          1,584              439            271               922       830     664     1,891   352   1,779   966     162   1,199   1,255   453
  Rutherford 6   163          398                151            84                201       264     213     412     87    440     226     46    291     321     100
  Total          1,558        2,428              697            442               1,428     1,255   1,141   2,996   546   2,864   1,530   289   1,910   2,002   771

Blood pressure management good: diabetes or renal failure (−) \<140/90 mmHg, (+) \<130/80 mmHg. Diabetes management good: HbA1c\<7.0%(NGSP). Dyslipidemia management good: other sclerotic lesions (−) LDL\<100 mg/DL, (+) LDL\<80 mg/DL. HbA1c: hemoglobin A1c, LDL: low-density lipoprotein, NGSP: national glycohemoglobin standardization program

###### Table 1-3 Patients' background 3

  a\. Total                                                                                                                                                               
  ------------------- ------------------------ --------------- ------------------------- ------------------- ------- ----- ------- ------- ------- ----- ----- ----- ---- -------
  Rutherford 4        703                      134             142                       100                 975     104   874     205     498     115   86    43    7    330
  Rutherford 5        1,671                    383             553                       375                 2,519   463   2,238   744     909     250   224   126   29   1,444
  Rutherford 6        364                      127             135                       97                  604     119   560     163     236     63    42    31    10   341
  Total               2,738                    644             830                       572                 4,098   686   3,672   1,112   1,643   428   352   200   46   2,115
  b\. ASO                                                                                                                                                                 
                      Ischemic heart disease   Heart failure   Cerebrovascular disease   Renal dysfunction                                                                
  (−)                 (+)                      (−)             (+)                       (−)                 (+)     (−)   (+)                                            
  Medical treatment   PCI                      CABG            G3a                       G3b                 G4      G5    G5D                                            
  Rutherford 4        688                      134             142                       100                 960     104   860     204     486     114   86    43    7    328
  Rutherford 5        1,611                    373             550                       373                 2,451   456   2,168   739     845     246   221   123   29   1,443
  Rutherford 6        356                      126             133                       97                  593     119   549     163     227     63    42    31    10   339
  Total               2,655                    633             825                       570                 4,004   679   3,577   1,106   1,558   423   349   197   46   2,110

PCI: percutaneous coronary intervention, CABG: coronary arterial bypass grafting Heart failure (+): history of admision due to heart failure, clinical symptoms due to heart failure confirmed by ultrasound examination, apparently decreased cardiac function by ultrasound examination without clinical symptoms. Renal dysfunction: (−) (60≦), G3a (45--59), G3b (30--44), G4 (15--29), G5 (\<15), G5D (\<15 with hemodialyais). New CKD risk stratification by eGFR (mL/min/1.73 m^2^) in "Clinical Practice Guidebook for Diagnosis and Treatment of Chronic Kidney Disease 2012" eGFR: estimated glomerular filtration rate, CKD: chronic kidney disease

###### Table 1-4 Patients' background 4

  a\. Total                                                                                                                                                                                     
  ------------------- -------------------- ----------------------------- ----------- ------ --------- ------------------------ ------- -------- -------- --------- ---------- -------- --- ---- ----
  Rutherford 4        962                  82                            33          2      5         2                        20      19       14       30        4          7        1   6    27
  Rutherford 5        2,727                180                           67          8      10        7                        35      49       15       65        13         7        0   13   51
  Rutherford 6        676                  34                            10          3      2         2                        10      7        1        11        2          5        0   3    9
  Total               4,365                296                           110         13     17        11                       65      75       30       106       19         19       1   22   87
  b\. ASO                                                                                                                                                                                       
                      Malignant neoplasm   Sites of malignant neoplasm                                                                                                                          
  (−)                 (+)                  Head and neck                 Esophagus   Lung   Stomach   Hepatobiliary pancreas   Colon   Breast   Uterus   Ovarian   Prostate   Others            
  History of cancer   Under treatment\*    Unknown                                                                                                                                              
  Rutherford 4        951                  80                            31          2      4         2                        20      19       14       30        4          5        1   6    26
  Rutherford 5        2,653                179                           67          8      10        7                        35      49       15       64        13         7        0   13   51
  Rutherford 6        666                  34                            9           3      2         2                        10      7        1        11        2          4        0   3    9
  Total               4,270                293                           107         13     16        11                       65      75       30       105       19         17       1   22   86

\*Including palliative therapy or recurrence

###### Table 1-5 Patients' background 5

  a\. Total                                                                                                                                                                                                                                                                
  -------------- -------------------------------------- -------------------------------------- ---------------- -------- ----- -------- ----- -------- --------------------- ---------------------------- ------------------ -------- ------ ------- ---- ----- ---- ----- -----
  Rutherford 4   304                                    241                                    177              168      35    1        153   781      0.8                   78                           0.45               302      39     970     1    44    7    35    22
  Rutherford 5   654                                    797                                    238              90       578   30       595   2,069    0.77                  261                          0.42               1,274    35     2,626   20   79    15   169   73
  Rutherford 6   152                                    196                                    51               15       52    81       176   371      0.76                  24                           0.36               258      35.5   657     2    12    3    35    14
  Total          1,110                                  1,234                                  466              273      665   112      924   3,221    0.78                  363                          0.43               1,834    35     4,253   23   135   25   239   109
  b\. ASO                                                                                                                                                                                                                                                                  
                 Contralateral limb occlusive lesions   Vascular lesions excluding occlusion                                                                                                                                                                               
  (−)            (+)                                                                                                                                                                                                                                                       
  Asymptomatic   Intermittent claudication              CLI                                    Post-treatment   ABI      TBI   SPP      (−)   TAA      AAA (including IAA)   Peripheral artery aneurysm   Carotid stenosis   Others                                        
  R4             R5                                     R6                                     n                Median   n     Median   n     Median                                                                                                                       
  Rutherford 4   297                                    238                                    176              164      35    1        153   771      0.8                   77                           0.45               300      39     957     1    43    7    35    21
  Rutherford 5   629                                    789                                    233              90       554   29       583   2,017    0.76                  251                          0.41               1,249    35     2,566   19   77    10   168   67
  Rutherford 6   149                                    195                                    51               14       51    79       173   367      0.76                  24                           0.36               256      35.5   647     2    12    3    34    14
  Total          1,075                                  1,222                                  460              268      640   109      909   3,155    0.77                  352                          0.42               1,805    35     4,170   22   132   20   237   102

ABI: ankle brachial (pressure) index, TBI: toe brachial (pressure) index, SPP: skin perfusion pressure, CLI: critical limb ischemia, TAA: thoracic aortic aneurysm, AAA: abdominal aortic aneurysm, IAA: iliac artery aneurysm

###### Table 1-6 Patients' background 6

  a\. Total (=ASO)                                                                                                             
  ----------------------- ----------------------------- ---------------------------- -------- ------ -------- ------- -------- ------
  Rutherford 4            31                            156                          31       62.6   31       113.7   31       0.35
  Rutherford 5            69                            153.6                        69       50.2   69       111.2   69       0.34
  Rutherford 6            18                            129.2                        18       50.1   18       100.6   18       0.31
  Total                   118                           153.8                        118      51.6   118      107.2   118      0.33
  b\. ASO                                                                                                                      
                          Fatty acid                                                                                           
  Arachidonic acid (AA)   Eicosapentaenoic acid (EPA)   Docosahexaenoic acid (DHA)   EPA/AA                                    
  n                       Median                        n                            Median   n      Median   n       Median   
  Rutherford 4            31                            156                          31       62.6   31       113.7   31       0.35
  Rutherford 5            69                            153.6                        69       50.2   69       111.2   69       0.34
  Rutherford 6            17                            125                          17       54.5   17       104.3   17       0.33
  Total                   117                           153.6                        117      51.6   117      107.2   117      0.34

The causes of the arterial occlusion of the limb were ASO in 4,683 (98%) limbs, thromboangitis obliterans (TAO) in 37, vasculitis (Takayasu's arteritis, collagen disease, Behçet's disease, and fibromuscular dysplasia excluding TAO) in 43, and others in 21. Patients comorbidities consisted of diabetes in 66% (67%) of the limbs, hypertension in 75% (76%), dyslipidemia in 39% (39%), ischemic heart disease in 43% (43%), heart failure 14% (14%), cerebrovascular disease in 23% (24%), dialysis for renal failure in 44% (45%), past medical history of malignant neoplasm or that being treated in 8% (9%), arterial occlusive lesions in the contralateral limb in 77% (77%), and CLI in the contralateral limb (Rutherford 4--6) in 22% (22%).

(2) Conditions of limb ischemia
-------------------------------

Limb ischemia pretreatment conditions are shown in [**Tables 2-1**](#table2-1){ref-type="table"} to [](#table2-2){ref-type="table"}[](#table2-3){ref-type="table"}[](#table2-4){ref-type="table"}[](#table2-5){ref-type="table"}[**2-6**](#table2-6){ref-type="table"}. Regarding the walking function (Taylor's classification),^[@R12])^ patients who could walk outdoors or indoors independently, including with a cane, were regarded as "ambulatory," and those unable to walk but able to stand on their own legs during transfer from the bed to a wheelchair were designated as "ambulatory/homebound."

###### Table 2 Pretreatment condition Table 2-1 Pretreatment condition 1

  a\. Total                                                                                                                                                                                                                                                                                                                         
  -------------- ----------------------------------------------- --------------------------------------------------------- ----------------------------------------------------------- ----------------------------- ----- ------- ------- ------- ------------------------- --------------------------- ------ ------- ----------- -----
  Rutherford 4   782                                             168                                                       129                                                                                                                                                                                                      
  Rutherford 5   1,679                                           708                                                       595                                                         1,798                         568   616     2,104   882     2,301                     392                         53     163     30          43
  Rutherford 6   237                                             216                                                       270                                                         126                           174   423     237     487     152                       190                         151    139     29          62
  Total          2,698                                           1,092                                                     994                                                         1,924                         742   1,039   2,341   1,369   2,453                     582                         204    302     59          105
  b\. ASO                                                                                                                                                                                                                                                                                                                           
                 Ambulatory function (Taylor's classification)   Tissue loss (University of Texas classification: grade)   Tissue loss\* (University of Texas classification: stage)   Sites of ulcer/gangrene^\#^                                                                                                                  
  Ambulatory     Ambulatory/homebound                            Nonambulatory                                             I                                                           II                            III   C       D       Toe     Foot: distal metatarsal   Foot: proximal metatarsal   Heel   Ankle   Lower leg   
  Rutherford 4   769                                             166                                                       129                                                                                                                                                                                                      
  Rutherford 5   1,618                                           697                                                       592                                                         1,747                         551   609     2,051   859     2,249                     373                         52     161     30          42
  Rutherford 6   233                                             211                                                       268                                                         125                           170   417     233     480     149                       186                         150    136     29          62
  Total          2,620                                           1,074                                                     989                                                         1,872                         721   1,026   2,284   1,339   2,398                     559                         202    297     59          104

University of Texas classification: grade (I: superficial, not involving tendon, capsule, or bone, II: penetrating to tendon/capsule, III: penetrating to bone or joint) University of Texas classification: stage (C: ischemia without infection, D: ischemia with infection) \*Data in "infection" in [**Table 3-2**](#table3-2){ref-type="table"} were used in 2015 and 2016. ^\#^Data in "main sites of ulcer/gangrene to be treated" were used in 2015 and 2016.

###### Table 2-2 Pretreatment condition 2

  a\. Total                                                                                                                                                      
  -------------- ------------------- ------------ -------------- ------- -------- ------ -------- ------ -------- ------ -------- ------ -------- ------ ------- ----
  Rutherford 4   1,056               23           1,040          6,600   976      0.42   964      3.7    1,030    1.09   586      0.54   43       0.36   385     20
  Rutherford 5   2,855               127          2,919          7,100   2,814    1.03   2,755    3.4    2,922    2.39   1,914    0.6    159      0.31   1,801   22
  Rutherford 6   618                 105          707            8,800   692      4.51   672      3      704      2.18   337      0.61   12       0.18   348     21
  Total          4,529               255          4,666          7,150   4,482    1.1    4,391    3.4    4,656    1.6    2,837    0.59   214      0.31   2,534   21
  b\. ASO                                                                                                                                                        
                 Temperature \>38°   Blood test   Hemodynamics                                                                                                   
  (−)            (+)                 WBC          CRP            Alb     Cr       ABI    TBI      SPP                                                            
  n              Median              n            Median         n       Median   n      Median   n      Median   n      Median   n      Median                  
  Rutherford 4   1,042               22           1,026          6,600   962      0.42   952      3.65   1,016    1.1    579      0.54   43       0.36   382     20
  Rutherford 5   2,784               123          2,846          7,100   2,745    1.05   2,686    3.4    2,849    2.75   1,864    0.6    152      0.3    1,760   22
  Rutherford 6   608                 104          697            8,800   682      4.58   662      2.95   694      2.3    332      0.61   12       0.18   343     21
  Total          4,434               249          4,569          7,130   4,389    1.1    4,300    3.4    4,559    1.7    2,775    0.59   207      0.3    2,485   21

WBC: white blood cell, CRP: C reactive protein, Alb: albumin, Cr: creatinine, ABI: ankle brachial (pressure) index, TBI: toe brachial (pressure) index, SPP: skin perfusion pressure

###### Table 2-3 Pretreatment condition 3

  a\. Total                                                                                                                                                                                                                       
  -------------- -------------------- -------------------- ----------------------------------- ---------------------------------------- ---------------- ------- ----- ----- ----- ----------- ---- ----- ----- ----- ----------- -----
  Rutherford 4   663                  609                  94                                  363                                      715              446     62    57    41    162         10   65    117   132   481         52
  Rutherford 5   2,186                1,360                102                                 574                                      1,807            1,973   191   109   61    186         13   331   387   366   1,201       426
  Rutherford 6   551                  279                  36                                  146                                      404              507     39    38    12    43          4    54    61    75    328         110
  Total          3,400                2,248                232                                 1,083                                    2,926            2,926   292   204   114   391         27   450   565   573   2,010       588
  b\. ASO                                                                                                                                                                                                                         
                 Diagnostic imaging   Sites of occlusion   TASC II classification aortoiliac   TASC II classification femoropopliteal                                                                                             
  IADSA          CTA                  Others               Aortoiliac                          Femoropop                                Lower leg/foot   A       B     C     D     No lesion   A    B     C     D     No lesion   
  Rutherford 4   655                  600                  94                                  358                                      708              437     61    56    39    161         10   65    116   132   472         52
  Rutherford 5   2,124                1,331                100                                 569                                      1,781            1,912   191   108   61    182         13   328   385   358   1,170       400
  Rutherford 6   542                  274                  36                                  144                                      399              500     39    38    12    42          3    54    61    74    324         108
  Total          3,321                2,205                230                                 1,071                                    2,888            2,849   291   202   112   385         26   447   562   564   1,966       560

IADSA: intra-arterial digital subtraction angiography, CTA: computed tomography angiography

###### Table 2-4 Pretreatment condition 4

  a\. Total                                                                                                                                                                                                              
  ---------------- ----------------- ------------------------------- ----------------------------- --------------------- ------------------- --------------------- -------- ----- -------- ----- -------- ----- -------- -----
  Rutherford 4     657               2.0                             654                           2.0                   648                 6.0                   647      6.0   645      3.0   644      3.0   630      3.0
  Rutherford 5     2,088             1.0                             2,085                         1.0                   2,090               4.0                   2,086    4.0   2,093    3.0   2,096    2.0   2,059    3.0
  Rutherford 6     476               1.0                             473                           1.0                   479                 3.0                   475      4.0   476      3.0   477      2.0   476      3.0
  Total            3,221             1.0                             3,212                         1.0                   3,217               4.0                   3,208    5.0   3,214    3.0   3,217    2.0   3,165    3.0
  b\. ASO                                                                                                                                                                                                                
                   Bollinger score                                                                                                                                                                                       
  Common femoral   Deep femoral      Superficial femoral: proximal   Superficial femoral: distal   Popliteal: proximal   Popliteal: distal   Tibioperoneal trunk                                                         
  n                Median            n                               Median                        n                     Median              n                     Median   n     Median   n     Median   n     Median   
  Rutherford 4     650               2.0                             647                           2.0                   641                 6.0                   640      6.0   638      3.0   637      3.0   623      3.0
  Rutherford 5     2,047             1.0                             2,040                         1.0                   2,045               4.0                   2,040    4.0   2,047    3.0   2,049    2.0   2,013    3.0
  Rutherford 6     472               1.0                             469                           1.0                   475                 3.0                   471      4.0   472      3.0   473      2.0   472      3.0
  Total            3,169             1.0                             3,156                         1.0                   3,161               4.0                   3,151    5.0   3,157    3.0   3,159    2.0   3,108    3.0

###### Table 2-5 Pretreatment condition 5

  a\. Total                                                                                                                                                                                                           
  ---------------------------- -------------------------- --------------------------- ------------------------- -------------------- ------------------ ------ -------- ------ -------- ----- -------- ----- -------- ------
  Rutherford 4                 624                        6.0                         614                       6.0                  621                7.0    602      13.0   620      5.0   601      5.0   512      4.0
  Rutherford 5                 2,039                      13.0                        2,003                     13.0                 2,037              13.0   2,006    13.0   2,032    6.0   2,000    6.0   1,735    13.0
  Rutherford 6                 473                        13.0                        466                       13.0                 474                13.0   464      13.0   475      6.0   467      6.0   426      13.0
  Total                        3,136                      13.0                        3,083                     13.0                 3,132              13.0   3,072    13.0   3,127    6.0   3,068    6.0   2,663    6.0
  b\. ASO                                                                                                                                                                                                             
                               Bollinger score                                                                                                                                                                        
  Posterior tibial: proximal   Posterior tibial: distal   Anterior tibial: proximal   Anterior tibial: distal   Peroneal: proximal   Peroneal: distal   Foot                                                          
  n                            Median                     n                           Median                    n                    Median             n      Median   n      Median   n     Median   n     Median   
  Rutherford 4                 617                        6.0                         608                       6.0                  614                6.0    595      13.0   613      5.0   595      5.0   507      4.0
  Rutherford 5                 1,991                      13.0                        1,955                     13.0                 1,989              13.0   1,958    13.0   1,984    6.0   1,953    6.0   1,694    12.0
  Rutherford 6                 469                        13.0                        462                       13.0                 470                13.0   460      13.0   471      6.0   463      6.0   412      13.0
  Total                        3,077                      13.0                        3,025                     13.0                 3,073              13.0   3,013    13.0   3,068    6.0   3,011    6.0   2,613    6.0

Regarding the state of local tissue defect (University Texas classification),^[@R13])^ the most severe lesion, the main treatment target, was evaluated. Skin perfusion pressure (SPP) was measured on the foot (base of the toe, dorsum of the foot, or sole) and a lower value was adopted. To perform WIfI classification, the sites of ulcer and gangrene were registered separately. Although SPP is widely used as an objective index for evaluating ischemia in Japan, ischemic grading criteria using SPP is not shown in WIfI classification, wherein TP is given top priority. Therefore, in JCLIMB, the SPP value was converted to TP using the conversion equation SPP=0.6853 TP+14.48 from the correlation data of SPP and TP reported in Japan,^[@R14])^ and applied for WIfI ischemic grading.

The lesion was considered infected when it showed two or more of the following findings: local swelling or induration, erythema \>0.5 cm around the ulcer, local tenderness or pain, local warmth, and purulent discharge (thick, opaque to white, or sanguineous secretion). In addition, local infections involving only the skin and the subcutaneous tissue, and those involving structures deeper than the skin and subcutaneous tissues, were registered separately. Local infections involving only the skin and the subcutaneous tissue were differentiated based on the size of the erythema around the ulcer, ≦2 or \>2 cm.

Systemic inflammatory response syndrome, indicating systemic infection, was manifested by two or more of the following signs: temperature \>38°C or \<36°C, heart rate \>90 beats/min, respiratory rate \>20 breaths/min or PaCO~2~ \<32 mmHg, white blood cell count \>12,000 or \<4,000 cu/mm or 10% immature (band) forms. The arteries in the ankle joint region were classified as foot arteries.

On Taylor's classification, 56% (56%) of the patients were ambulatory, 23% (23%) were ambulatory/homebound, and 21% (21%) were non-ambulatory. On the Rutherford classification (R),^[@R15])^ limbs with categories R4, R5, and R6 accounted for 23% (23%), 62% (62%), and 15% (15%) of the limbs, respectively. The occlusive legion was located in the aortoiliac artery in 23% (23%) of the limbs, in the femoropopliteal artery in 61% (62%) of the limbs, and in the crural or foot artery in 61% (61%) of the limbs.

We were able to apply the WIfI classification with sufficient data to 1,724 limbs (1,689 limbs). On the WIfI classification, limbs with the stages 1, 2, 3, and 4 accounted for 11% (11%), 20% (19%), 27% (27%), and 43% (43%) of the limbs, respectively.

###### Table 2-6 SVS WIfI classification\*

  a\. Total                                                                                                                       
  -------------- ------- ---------- ---------------- ------- ----- ----- ----- ------- ------- ----- ----- ---- ----- ----- ----- -----
  Rutherford 4   476     0          0                0       35    55    55    177     435     20    18    3    86    218   16    2
  Rutherford 5   0       542        680              210     124   151   150   751     943     312   147   30   92    117   420   547
  Rutherford 6   0       21         77               224     23    27    18    158     103     60    131   28   5     4     30    187
  Total          476     563        757              434     182   233   223   1,086   1,481   392   296   61   183   339   466   736
  b\. ASO                                                                                                                         
                 Wound   Ischemia   Foot infection   Stage                                                                        
  0              1       2          3                0       1     2     3     0       1       2     3     1    2     3     4     
  Rutherford 4   469     0          0                0       35    55    53    173     429     19    18    3    86    213   15    2
  Rutherford 5   0       530        661              207     116   150   147   738     921     306   145   26   88    112   416   535
  Rutherford 6   0       21         75               221     23    27    17    155     102     60    127   28   5     4     30    183
  Total          469     551        736              428     174   232   217   1,066   1,452   385   290   57   179   329   461   720

\*Data registered only in 2015 and 2016

(3) Treatment
-------------

[**Tables 3-1**](#table3-1){ref-type="table"} to [](#table3-2){ref-type="table"}[](#table3-3){ref-type="table"}[](#table3-4){ref-type="table"}[](#table3-5){ref-type="table"}[**3-6**](#table3-6){ref-type="table"} show the CLI treatment data. Revascularizations of the affected limbs were performed in 95% (95%) of the registered limbs, and primary major amputations were performed in 1.9% (2.0%) of the registered limbs. Among the surgical reconstruction procedures, distal bypass, a bypass to the crural or foot artery, accounted for 46% (45%). Endovascular treatment (EVT) applied to the crural or foot artery accounted for 38% (37%) of the total EVT.

###### Table 3 Treatment Table 3-1 Treatment 1

  a\. Total                                                                                                                                                                                        
  ------------------------- -------------------- ------------------------- ------------------ ---------------------- ------------- ------------------ -------- --------- ----- ------- ----- ----- -----
  Rutherford 4              307                  5                         1,011              9                      0             0                  1        1         16    788     169   53    53
  Rutherford 5              821                  12                        2,868              32                     0             0                  1        3         42    2,161   476   138   165
  Rutherford 6              173                  2                         671                52                     2             0                  0        0         11    513     111   35    53
  Total                     1,301                19                        4,550              93                     2             0                  2        4         69    3,462   756   226   271
  b\. ASO                                                                                                                                                                                          
                            Treatment            Angiogenic therapy        Reoperation                                                                                                             
  Pharmacological therapy   Angiogenic therapy   Arterial reconstruction   Major amputation   Lumber sympathectomy   Bone marrow   Peripheral blood   Others   Unknown   (−)   (+)                 
  1X                        2X                   3X≦                                                                                                                                               
  Rutherford 4              305                  5                         997                9                      0             0                  1        1         16    775     169   53    51
  Rutherford 5              799                  12                        2,796              32                     0             0                  1        3         42    2,107   465   135   158
  Rutherford 6              171                  2                         662                52                     2             0                  0        0         11    507     108   35    51
  Total                     1,275                19                        4,455              93                     2             0                  2        4         69    3,389   742   223   260

###### Table 3-2 Treatment 2

  a\. Total                                                                                                                                                                                                                                                                                                
  -------------- ------------------------------- ---------------- ---------------------------- -------------------------- --------------------- ----------------------- ------------------- ------------------ ----------------- ------------------------- ------------- ------------------- -------- ---- -------
  Rutherford 4   4                               2                30                           151                        64                    133                     67                  13                 31                67                        14            7                   94       18   489
  Rutherford 5   0                               2                42                           246                        161                   384                     486                 22                 48                63                        11            12                  210      25   1,529
  Rutherford 6   0                               0                6                            57                         40                    106                     111                 4                  13                17                        6             2                   35       7    330
  Total          4                               4                78                           454                        265                   623                     664                 39                 92                147                       31            21                  339      50   2,348
  b\. ASO                                                                                                                                                                                                                                                                                                  
                 Bypass                          TEA              EVT                                                                                                                                                                                                                                      
  Aorta--aorta   Aorta (with suprarenal clamp)   Aorta--femoral   Femoral-proximal popliteal   Femoral-distal popliteal   Femoral-crural/foot   Popliteal-crural/foot   Anatomical others   Axillary-femoral   Femoral-femoral   Extra-anatomical others   Aorta/iliac   Fomoral/popliteal   Others        
  Rutherford 4   4                               2                30                           151                        63                    129                     64                  12                 31                65                        13            6                   94       17   487
  Rutherford 5   0                               2                42                           243                        157                   373                     462                 19                 47                62                        11            12                  208      24   1,501
  Rutherford 6   0                               0                6                            55                         40                    104                     108                 4                  12                17                        5             2                   35       7    328
  Total          4                               4                78                           449                        260                   606                     634                 35                 90                145                       29            20                  337      48   2,316

TEA: thromboendarterectomy, EVT: endovascular treatment/therapy

###### Table 3-3 Treatment 3

  a\. Total                                                                                                                                                                          
  -------------- ------------------- --------------------- -------------- ---------------- ------- ------ -------- ----- --------- -------------- ---------- --------- ------ ------ ----
  Rutherford 4   179                 226                   152            25               65      191    301      25    43        29             53         51        14     123    16
  Rutherford 5   374                 709                   769            44               106     282    1,102    4     86        102            149        210       43     426    70
  Rutherford 6   81                  145                   169            20               23      58     266      2     38        18             50         42        6      102    10
  Total          634                 1,080                 1,090          89               194     531    1,669    31    167       149            252        303       63     651    96
  b\. ASO                                                                                                                                                                            
                 EVT                 Vascular prosthesis   Vein usage\*   Vein quality\*                                                                                             
  Aorta/iliac    Fomoral/popliteal   Tibioperoneal/foot    Others         Polyester        ePTFE   Vein   Others   (−)   In-situ   Non-reversed   Reversed   Spliced   Good   Poor   
  Rutherford 4   179                 226                   150            25               63      189    294      25    42        27             53         48        14     118    16
  Rutherford 5   373                 706                   747            42               105     277    1,066    4     85        101            141        201       43     411    68
  Rutherford 6   81                  144                   167            20               23      57     260      2     37        18             47         41        5      98     10
  Total          633                 1,076                 1,064          87               191     523    1,620    31    164       146            241        290       62     627    94

ePTFE: expanded polytetrafluoroethylene \*Data registered only in 2015 and 2016

###### Table 3-4 Treatment 4

  a\. Total                                                                                                                                                                                                                                                                                                                                                      
  ---------------------- -------------------- -------------------------------------------- ------------------------------------------ -------------------- ------------------ -------- -------- -------- ------ --------------------- ------------------ ----------------- ---------- ------------------ ----------------- ---------- ---------------- --------- ----
  Rutherford 4           1                    73                                           10                                         47                   26                 34       5        4        129    71                    12                 76                22         20                 24                7          2                33        6
  Rutherford 5           7                    202                                          27                                         163                  111                305      34       19       324    544                   17                 173               99         36                 143               54         4                268       76
  Rutherford 6           2                    50                                           4                                          42                   35                 70       14       1        89     128                   7                  40                33         11                 36                18         2                60        13
  Total                  10                   325                                          41                                         252                  172                409      53       24       542    743                   36                 289               154        67                 203               79         8                361       95
  b\. ASO                                                                                                                                                                                                                                                                                                                                                        
                         Distal bypass                                                                                                                                                                                                                                                                                                                           
  Proximal anastomosis   Distal anastomosis   Distal anastomosis: sites of crural artery   Distal anastomosis: sites of foot artery                                                                                                                                                                                                                              
  External iliac         Common femoral       Deep femoral                                 Superficial femoral                        Proximal popliteal   Distal popliteal   Crural   Others   Crural   Foot   Tibioperoneal trunk   Posterior tibial   Anterior tibial   Peroneal   Posterior tibial   Anterior tibial   Peroneal   Dorsalis pedis   Plantar   
  Rutherford 4           1                    69                                           10                                         47                   25                 32       5        4        124    69                    12                 73                20         20                 22                7          2                33        6
  Rutherford 5           6                    199                                          26                                         154                  107                289      33       19       310    523                   17                 171               94         29                 140               53         3                263       65
  Rutherford 6           2                    49                                           4                                          41                   34                 68       14       1        86     126                   7                  39                31         11                 36                18         2                59        12
  Total                  9                    317                                          40                                         242                  166                389      52       24       520    718                   36                 283               145        60                 198               78         7                355       83

###### Table 3-5 Treatment 5

  a\. Total                                                                            
  -------------- ------------------------- --------------- --------- -------- -------- -----
  Rutherford 4   501                       56              44        34       69       31
  Rutherford 5   1,413                     175             181       115      162      56
  Rutherford 6   290                       30              43        27       28       15
  Total          2,204                     261             268       176      259      102
  b\. ASO                                                                              
                 Pharmacological therapy                                               
  Antiplatelet   ATA                       Prostaglandin   Heparin   Statin   Others   
  Rutherford 4   499                       56              44        34       69       31
  Rutherford 5   1,376                     168             172       108      158      51
  Rutherford 6   287                       30              42        26       28       15
  Total          2,162                     254             258       168      255      97

Antiplatelet: aspirin, cilostazol, beraprost, sarpogrelate, ticlopidine, clopidogrel, ethyl icosapentate ATA: antithrombotic agent

###### Table 3-6 Treatment 6

  a\. Total                                                                                                      
  ----------- ----------------------------------- --------------------------------- ---------------------------- ------------------------------
  Polyester   56                                  13                                9                            9
  ePTFE       251                                 58                                30                           39
  Vein        160                                 210                               588                          623
  Artery      5                                   1                                 18                           26
  Others      14                                  0                                 2                            1
  (−)         5                                   4                                 5                            6
  Total       491                                 286                               652                          704
  b\. ASO                                                                                                        
              Femoral-proximal popliteal bypass   Femoral-distal popliteal bypass   Femoral-crural/foot bypass   Popliteal-crural/foot bypass
  Polyester   55                                  13                                9                            9
  ePTFE       251                                 57                                29                           39
  Vein        156                                 206                               573                          597
  Artery      5                                   1                                 16                           22
  Others      14                                  0                                 2                            1
  (−)         5                                   1                                 5                            6
  Total       486                                 281                               614                          674

ePTFE: expanded polytetrafluoroethylene

(4) Outcomes early (one month) after treatment
----------------------------------------------

[**Tables 4-1**](#table4-1){ref-type="table"} to [](#table4-2){ref-type="table"}[](#table4-3){ref-type="table"}[](#table4-4){ref-type="table"}[](#table4-5){ref-type="table"}[](#table4-6){ref-type="table"}[](#table4-7){ref-type="table"}[**4-8**](#table4-8){ref-type="table"} show the outcomes early (one month) after treatment. Follow-up data one month after treatment were obtained in 3,188 limbs (67%), including 3,115 limbs (67%) with ASO, which included 105 limbs (102 limbs) without arterial reconstruction. Data were collected according to the severity of the local limb conditions (Rutherford classification) and treatment measures (EVT alone or surgical reconstruction with/without EVT). The mortality was 3.2% (3.2%) in the whole series, and 3.0% (3.1%) and 3.3% (3.3%) treated by EVT alone and by surgical reconstruction with/without EVT, respectively. The most common cause of death was cardiac disease, accounting for 31% (31%) of all deaths. Postoperative complications were cardiac disease in 2.9% (2.9%), cerebrovascular disease in 1.4% (1.4%), pneumonia in 1.9% (1.9%), and wound complication in 5.3% (5.0%). Complications at the puncture site were noted in 0.4% (0.4%) of the limbs treated by EVT.

###### Table 4 One month after the treatment (data collection at July 2015) therapeutic measures: EVT (only EVT without surgical reconstruction), surgical reconstruciton (surgical reconstruction with or without EVT) Table 4-1 Life prognosis/causes of death

  a\. Total                                                                                                                                                                                                                                                        
  ------------------------- -------------------- ----------------- ----------------- ------------------------- -------------------- ---------------------------- ----------- -------------------- --------------------------- -------- --------- --- --- ---- ---- ---
  Local condition           Rutherford 4         637               20                6                         3                    0                            1           0                    2                           0        1         1   1   0    8    3
  Rutherford 5              1,976                64                23                21                        0                    3                            0           4                    0                           9        2         5   0   13   7    
  Rutherford 6              440                  17                5                 7                         1                    0                            0           0                    0                           1        4         1   0   1    2    
  Therapeutic measures      Non-reconstruction   102               3                 0                         1                    1                            0           0                    0                           0        1         0   0   0    0    0
  EVT                       1,343                43                24                16                        0                    1                            0           5                    0                           8        0         2   0   8    3    
  Surgical reconstruction   1,608                55                10                14                        0                    3                            0           1                    0                           2        7         5   0   14   9    
  Total                     3,053                101               34                31                        1                    4                            0           6                    0                           11       7         7   0   22   12   
  b\. ASO                                                                                                                                                                                                                                                          
                            Life prognosis       Causes of death                                                                                                                                                                                                   
  Alive                     Dead                 Unknown           Cardiac disease   Cerebrovascular disease   Malignant neoplasm   Aortic aneurysm/dissection   Infection   Ischemic enteritis   Gastrointestinal bleeding   Others   Unknown                     
  Hemorrhage                Infarction           Unknown           Diseased limb     Others                                                                                                                                                                        
  Local condition           Rutherford 4         627               19                6                         3                    0                            1           0                    1                           0        1         1   1   0    8    3
  Rutherford 5              1,921                64                23                21                        0                    3                            0           4                    0                           9        2         5   0   13   7    
  Rutherford 6              434                  17                5                 7                         1                    0                            0           0                    0                           1        4         1   0   1    2    
  Therapeutic measures      Non-reconstruction   99                3                 0                         1                    1                            0           0                    0                           0        1         0   0   0    0    0
  EVT                       1,322                43                23                16                        0                    1                            0           5                    0                           8        0         2   0   8    3    
  Surgical reconstruction   1,561                54                10                14                        0                    3                            0           0                    0                           2        7         5   0   14   9    
  Total                     2,982                100               33                31                        1                    4                            0           5                    0                           11       7         7   0   22   12   

###### Table 4-2 Perioperative complications 1

  a\. Total                                                                                                                                                                                                                        
  ------------------------- --------------------- ---------------------------- ----------------------- -------------------- --------------------- --------------------- ----- ----- ------- ----- ------- ----- ------- ----- ---- ---
  Local condition           Rutherford 4          595                          12                      4                    7                     616                   0     0     2       606   12      595   23      614   3    1
  Rutherford 5              1,910                 29                           7                       15                   1,923                 6                     15    17    1,931   30    1,841   120   1,940   13    8    
  Rutherford 6              427                   5                            3                       7                    440                   0                     0     2     426     16    424     18    438     1     3    
  Therapeutic measures      Non-reconstruction    12                           1                       0                    1                     14                    0     0     0       14    0       14    0       14    0    0
  EVT                       1,336                 30                           4                       12                   1,364                 3                     8     7     1,367   15    1,361   21    1,369   6     7    
  Surgical reconstruction   1,584                 15                           10                      16                   1,601                 3                     7     14    1,582   43    1,485   140   1,609   11    5    
  Total                     2,932                 46                           14                      29                   2,979                 6                     15    21    2,963   58    2,860   161   2,992   17    12   
  b\. ASO                                                                                                                                                                                                                          
                            Cardiac disease       Cerebrovascular disease      Pneumonia               Wound complication   Peripheral embolism                                                                                    
  (−)                       Angina                Serious arrhysmia            Myocardial infarction   (−)                  TIA                   Cerebral infarction   (−)   (+)   (−)     (+)   (−)     (+)                      
  Functional loss (−)       Functional loss (+)   Minor (including blue toe)   Major                                                                                                                                               
  Local condition           Rutherford 4          584                          12                      4                    7                     605                   0     0     2       595   12      587   20      603   3    1
  Rutherford 5              1,859                 28                           7                       15                   1,871                 6                     15    17    1,879   30    1,796   113   1,889   12    8    
  Rutherford 6              421                   5                            3                       7                    434                   0                     0     2     421     15    420     16    433     1     2    
  Therapeutic measures      Non-reconstruction    12                           1                       0                    1                     14                    0     0     0       14    0       14    0       14    0    0
  EVT                       1,316                 29                           4                       12                   1,343                 3                     8     7     1,346   15    1,341   20    1,348   6     7    
  Surgical reconstruction   1,536                 15                           10                      16                   1,553                 3                     7     14    1,535   42    1,448   129   1,563   10    4    
  Total                     2,864                 45                           14                      29                   2,910                 6                     15    21    2,895   57    2,803   149   2,925   16    11   

TIA: transient ischemic attack

###### Table 4-3 Perioperative complications 2

  a\. Total                                                                                                                                                                                                                 
  ------------------------- -------------------- ------------------- --------------------- ------------------------------------- ------------------------------- ------- --------- ------ ----- ------- ----- ------- ----- ---
  Local condition           Rutherford 4         608                 10                    0                                     0                               3       14        9      0     1       617   1       315   5
  Rutherford 5              1,926                33                  2                     0                                     8                               17      28        3      2     1,953   8     1,089   12    
  Rutherford 6              436                  6                   0                     0                                     3                               5       3         3      0     440     2     221     1     
  Therapeutic measures      Non-reconstruction   14                  0                     0                                     0                               0       0         0      0     0       14    0       32    1
  EVT                       1,368                14                  0                     0                                     4                               10      11        2      0     1,376   6     1,371   17    
  Surgical reconstruction   1,588                35                  2                     0                                     10                              26      29        4      3     1,620   5     222     0     
  Total                     2,970                49                  2                     0                                     14                              36      40        6      3     3,010   11    1,625   18    
  b\. ASO                                                                                                                                                                                                                   
                            Hemorrhage           Sites of bleeding   Outcome of bleeding   Complication due to contrast medium   Complication at puncture site                                                              
  (−)                       (+)                  Unknown             Brain                 GI tract                              Others                          Cured   Uncured   Dead   (−)   (+)     (−)   (+)           
  Local condition           Rutherford 4         597                 10                    0                                     0                               3       14        9      0     1       606   1       314   5
  Rutherford 5              1,874                33                  2                     0                                     8                               17      28        3      2     1,901   8     1,069   12    
  Rutherford 6              430                  6                   0                     0                                     3                               5       3         3      0     434     2     220     1     
  Therapeutic measures      Non-reconstruction   14                  0                     0                                     0                               0       0         0      0     0       14    0       32    1
  EVT                       1,347                14                  0                     0                                     4                               10      11        2      0     1,355   6     1,350   17    
  Surgical reconstruction   1,540                35                  2                     0                                     10                              26      29        4      3     1,572   5     221     0     
  Total                     2,901                49                  2                     0                                     14                              36      40        6      3     2,941   11    1,603   18    

GI: gastrointestinal

###### Table 4-4 Hemodynamics

  a\. Total                                                                                                                                                                         
  ------------------------- ------------------------------- ------------------------------- -------- ---------------- -------- ----- -------- ------ -------- ----- -------- ------ ----
  Local condition           Rutherford 4                    376                             0.89     347              114      158   33.5     292    0.9      267   115      63     39
  Rutherford 5              937                             0.86                            871      114              779      39    663      0.88   592      120   359      42     
  Rutherford 6              145                             0.91                            134      124              130      36    106      1      99       128   68       45.5   
  Therapeutic measures      Non-reconstruction              46                              0.79     34               103.5    31    32       35     0.83     27    110      18     30
  EVT                       674                             0.85                            633      112              522      35    476      0.87   436      116   299      42     
  Surgical reconstruction   738                             0.89                            685      118              514      40    550      0.93   494      122   180      43     
  Total                     1,458                           0.87                            1,352    115              1,067    37    1,061    0.9    958      120   490      42     
  b\. ASO                                                                                                                                                                           
                            Immediate after the treatment   One month after the treatment                                                                                           
  ABI                       Ankle pressure                  SPP                             ABI      Ankle pressure   SPP                                                           
  n                         Median                          n                               Median   n                Median   n     Median   n      Median   n     Median          
  Local condition           Rutherford 4                    368                             0.89     341              114      156   33       286    0.9      262   115.5    63     39
  Rutherford 5              913                             0.85                            848      114              758      39    653      0.88   584      120   353      43     
  Rutherford 6              143                             0.91                            132      124.5            127      36    105      0.99   98       128   67       45     
  Therapeutic measures      Non-reconstruction              45                              0.77     33               101      30    29.5     34     0.87     27    110      17     32
  EVT                       668                             0.85                            628      112              521      35    472      0.87   433      116   298      42.5   
  Surgical reconstruction   711                             0.89                            660      118              490      40    538      0.93   483      123   174      43.5   
  Total                     1,424                           0.87                            1,321    115              1,041    38    1,044    0.9    944      120   483      43     

ABI: ankle brachial (pressure) index, SPP: skin perfusion pressure

###### Table 4-5 One month after the treatment

  a\. Total                                                                                                                                                                                                                                                                                                                   
  ------------------------- ---------------------------- ------------------------------- ---------------- ------------------------------------------------------------ ----------- -------- ---------- ----------- -------------- ------- --------- --------- ------------ ---------------------- --------------- ----- ----- ----
  Local condition           Rutherford 4                 560                             12               23                                                           0           0        4          2           563            51      18        416       142          38                     27              461   108   88
  Rutherford 5              1,747                        37                              90               0                                                            5           14       19         1,612       234            94      426       1,210     278          26                     1,086           459   499   
  Rutherford 6              360                          15                              29               0                                                            1           2        12         321         53             28      47        277       73           4                      126             137   195   
  Therapeutic measures      Non-reconstruction           0                               0                0                                                            0           0        0          0           49             11      4         20        31           8                      4               62    16    24
  EVT                       1,201                        41                              67               0                                                            0           8        28         1,027       217            77      338       736       219          28                     639             334   419   
  Surgical reconstruction   1,466                        23                              75               0                                                            6           12       5          1,420       110            59      531       862       162          25                     972             354   339   
  Total                     2,667                        64                              142              0                                                            6           20       33         2,496       338            140     889       1,629     389          57                     1,673           704   782   
  b\. ASO                                                                                                                                                                                                                                                                                                                     
                            Bypass graft/EVT condition   Clinical symptoms of the limb   Ischemic wound   Ambulatory function at discharge (Taylor's classification)                                                                                                                                                          
  Good                      Stenosis                     Occlusion                       Deterioration    Anastomosis disruption (aneurysm)                            Infection   Others   Improved   No change   Deteriorated   Cured   Uncured   Unknown   Ambulatory   Amburatory/homebound   Nonambulatory               
  Improved                  Deteriorated                                                                                                                                                                                                                                                                                      
  Local Condition           Rutherford 4                 551                             12               23                                                           0           0        3          2           553            51      18        408       140          38                     27              451   107   88
  Rutherford 5              1,705                        37                              81               0                                                            5           14       18         1,573       229            86      417       1,181     265          25                     1,045           449   495   
  Rutherford 6              357                          14                              27               0                                                            1           2        12         318         50             28      46        272       73           4                      124             134   194   
  Therapeutic Measures      Non-reconstruction           0                               0                0                                                            0           0        0          0           46             11      6         20        29           8                      3               60    16    27
  EVT                       1,186                        40                              63               0                                                            0           8        27         1,019       212            69      336       727       210          28                     624             330   414   
  Surgical reconstruction   1,427                        23                              68               0                                                            6           11       5          1,379       107            57      515       837       158          25                     936             344   336   
  Total                     2,613                        63                              131              0                                                            6           19       32         2,444       330            132     871       1,593     376          56                     1,620           690   777   

###### Table 4-6 Revision one month after the treatment

  a\. Total                                                                                                                                                                                                                                                                                                                                                   
  --------------------------- -------------------------------------------------------------- ---------------------------------------------- ----------------------------------------------- ------------------ -------- ----- ------------------------------ -------------- ----- ----------- ------------- --------------- -------- ----- ------- ----- ---- ---
  Local condition             Rutherford 4                                                   27                                             19                                              593                2        10    3                              582            10    0           2             10              4        0     0       623   9    3
  Rutherford 5                97                                                             75                                             1,848                                           2                  60       9     1,818                          18             0     10          35            18              2        18    1,889   72    6    
  Rutherford 6                41                                                             22                                             395                                             0                  16       2     375                            9              0     2           15            2               0        10    373     49    2    
  Therapeutic measures        Non-reconstruction                                             0                                              0                                               11                 0        1     1                              12             0     0           0             1               0        0     0       81    6    0
  EVT                         85                                                             67                                             1,273                                           1                  58       3     1,245                          8              0     8           40            13              2        19    1,263   73    2    
  Surgical reconstruction     80                                                             49                                             1,552                                           3                  27       10    1,518                          29             0     6           19            11              0        9     1,541   51    9    
  Total                       165                                                            116                                            2,836                                           4                  86       14    2,775                          37             0     14          60            24              2        28    2,885   130   11   
  b\. ASO                                                                                                                                                                                                                                                                                                                                                     
                              Revision for those excluding good bypass graft/EVT condition   Minor reintervention (revision for stenosis)   Major reintervention (revision for occlusion)   Major amputation                                                                                                                                                  
  (+)                         (−)                                                            (−)                                            Patch plasty                                    EVT                Others   (−)   Thrombectomy (±patch plasty)   Thrombolysis   EVT   Re-bypass   Jump bypass   Interposition   Others   (−)   (+)                
  Due to preoperative wound   Due to new wound                                                                                                                                                                                                                                                                                                                
  Local condition             Rutherford 4                                                   26                                             19                                              583                2        10    3                              573            9     0           2             10              4        0     0       614   9    2
  Rutherford 5                91                                                             71                                             1,796                                           2                  59       9     1,772                          17             0     10          32            18              2        15    1,837   70    5    
  Rutherford 6                38                                                             22                                             391                                             0                  15       1     371                            8              0     2           15            2               0        9     367     49    2    
  Therapeutic measures        Non-reconstruction                                             0                                              0                                               10                 0        1     0                              11             0     0           0             1               0        0     0       78    6    0
  EVT                         80                                                             66                                             1,253                                           1                  57       3     1,229                          8              0     8           38            13              2        16    1,243   72    2    
  Surgical reconstruction     75                                                             46                                             1,507                                           3                  26       10    1,476                          26             0     6           18            11              0        8     1,497   50    7    
  Total                       155                                                            112                                            2,770                                           4                  84       13    2,716                          34             0     14          57            24              2        24    2,818   128   9    

###### Table 4-7 Contralateral limb one month after the treatment

  a\. Total                                                                                                                                                                                                                                                                                                               
  ------------------------- -------------------------------------- ---------------------------------- ---------------- ------------------------- -------------------- ----- ----------------- ------------------ ------------------ ---------------------- ---------------------------- -------- ---- ----- --- ---- ---- ---
  Local condition           Rutherford 4                           234                                192              56                        29                   9     2                 135                41                 284                    3                            73       63   4     9   0    5    1
  Rutherford 5              569                                    668                                127              44                        162                  14    460               191                867                6                      206                          204      33   90    0   33   11   
  Rutherford 6              127                                    156                                14               10                        31                   12    107               58                 192                0                      53                           33       8    23    0   6    4    
  Therapeutic measures      Non-reconstruction                     49                                 26               5                         4                    2     2                 18                 3                  39                     0                            11       7    1     2   0    2    0
  EVT                       399                                    415                                81               40                        103                  17    333               124                601                7                      215                          68       17   75    0   21   8    
  Surgical reconstruction   482                                    575                                111              39                        97                   9     351               163                703                2                      106                          225      27   45    0   21   8    
  Total                     930                                    1,016                              197              83                        202                  28    702               290                1,343              9                      332                          300      45   122   0   44   16   
  b\. ASO                                                                                                                                                                                                                                                                                                                 
                            Contralateral limb occlusive lesions   Treatment for contralateral limb                                                                                                                                                                                                                       
  (−)                       (+)                                    Unnecessary                        (+)                                                                                                                                                                                                                 
  Asymptomatic              Intermittent claudication              CLI                                Post-treatment   Pharmacological therapy   Angiogenic therapy   EVT   Surgical bypass   Minor amputation   Major amputation   Lumber sympathectomy   Necessary but no treatment   Others                            
  R4                        R5                                     R6                                                                                                                                                                                                                                                     
  Local condition           Rutherford 4                           227                                192              55                        27                   9     2                 134                41                 280                    3                            73       63   4     9   0    5    0
  Rutherford 5              544                                    654                                127              43                        157                  14    450               186                850                6                      205                          201      31   86    0   33   11   
  Rutherford 6              124                                    155                                14               10                        31                   12    105               56                 192                0                      52                           33       8    23    0   6    4    
  Therapeutic measures      Non-reconstruction                     46                                 26               5                         4                    2     2                 15                 2                  39                     0                            11       7    1     2   0    2    0
  EVT                       387                                    412                                81               40                        101                  17    331               123                596                7                      214                          68       17   73    0   21   8    
  Surgical reconstruction   462                                    563                                110              36                        94                   9     343               158                687                2                      105                          222      25   43    0   21   7    
  Total                     895                                    1,001                              196              80                        197                  28    689               283                1,322              9                      330                          297      43   118   0   44   15   

CLI: critical limb ischemia

###### Table 4-8 Malignant neoplasm one month after the treatment

  a\. Total                                                                                                                                                                                                                                      
  ------------------------- ------------------------------------ --------------------------------------------- --------------- ----------- ------ --------- ------------------------ ------- -------- -------- --------- ---------- -------- --- ---
  Local condition           Rutherford 4                         646                                           3               8           0      0         1                        0       0        0        0         0          0        0   2
  Rutherford 5              2,013                                9                                             23              2           1      3         1                        0       1        1        0         0          0        1   
  Rutherford 6              454                                  1                                             3               0           0      0         1                        0       0        0        0         0          0        0   
  Therapeutic measures      Non-reconstruction                   101                                           0               5           0      0         0                        0       0        0        0         0          0        0   0
  EVT                       1,369                                7                                             14              1           0      0         2                        0       1        1        0         0          0        2   
  Surgical reconstruction   1,643                                6                                             15              1           1      4         0                        0       0        0        0         0          0        1   
  Total                     3,113                                13                                            34              2           1      4         2                        0       1        1        0         0          0        3   
  b\. ASO                                                                                                                                                                                                                                        
                            Newly diagnosed malignant neoplasm   Sites of newly diagnosed malignant neoplasm                                                                                                                                     
  (−)                       (+)                                  Unknown                                       Head and neck   Esophagus   Lung   Stomach   Hepatobiliary pancreas   Colon   Breast   Uterus   Ovarian   Prostate   Others       
  Local condition           Rutherford 4                         635                                           3               8           0      0         1                        0       0        0        0         0          0        0   2
  Rutherford 5              1,959                                9                                             22              2           1      3         1                        0       1        1        0         0          0        1   
  Rutherford 6              448                                  1                                             3               0           0      0         1                        0       0        0        0         0          0        0   
  Therapeutic measures      Non-reconstruction                   98                                            0               5           0      0         1                        0       0        0        0         0          0        0   0
  EVT                       1,348                                7                                             14              1           0      0         2                        0       1        1        0         0          0        3   
  Surgical reconstruction   1,596                                6                                             14              1           1      3         0                        0       0        0        0         0          0        0   
  Total                     3,042                                13                                            33              2           1      4         2                        0       1        1        0         0          0        3   

Stenosis, occlusion, infection, or other trouble occurred after revascularization by EVT in 10.7% (10.4%) and by surgical reconstruction in 7.6% (7.3%). Secondary major amputation rate was 4.7% (4.6%). When ambulatory function at discharge was compared to that before surgery, the rate of patients with ambulatory changed from 56% (56%) to 53% (52%), ambulatory/homebound from 23% (23%) to 22% (22%), and non-ambulatory from 21% (21%) to 25% (25%).

4. Conclusions
==============

Vascular surgeons' contribution in participating facilities registered a sufficient amount of detailed data during busy clinical practice, which has clarified the current status of CLI treatment in Japan from 2013 to 2016. The JCLIMB Committee is planning to continue publishing an annual report and try to clarify the real clinical status of CLI treatment in Japan. Additionally, clinical studies using these data began in 2018. Facilities can participate in JCLIMB at any time and can get detail information about clinical research by contacting the JSVS secretariat for details.
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